Latest period
$2.68B
YoY change
+14.7%
5Y CAGR
-10.3%
Peak year (2021)
$10.74B
Latest annual
$2.72B
Total Equity history chart for Illumina (ILMN) from 1999 to 2025
Latest: $2.72B
Total Equity growth chart for Illumina (ILMN) from 1999 to 2025
Latest: +14.7%
Total Equity history table for Illumina (ILMN) from 1999 to 2025
| 2025 | $2.72B | +14.7% | +$350.00M | ||
| 2024 | $2.37B | -58.7% | −$3.37B | ||
| 2023 | $5.75B | -12.9% | −$854.00M | ||
| 2022 | $6.60B | -38.6% | −$4.14B | ||
| 2021 | $10.74B | +128.8% | +$6.05B | ||
| 2020 | $4.69B | +1.8% | +$81.00M | ||
| 2019 | $4.61B | +20.0% | +$768.00M | ||
| 2018 | $3.85B | +35.2% | +$1.00B | ||
| 2017 | $2.84B | +25.3% | +$573.76M | ||
| 2016 | $2.27B | +22.8% | +$421.68M | ||
| 2015 | $1.85B | +26.4% | +$385.75M | ||
| 2014 | $1.46B | -4.6% | −$70.40M | ||
| 2013 | $1.53B | +16.3% | +$214.62M | ||
| 2012 | $1.32B | +22.6% | +$243.37M | ||
| 2011 | $1.08B | -10.2% | −$122.46M | ||
| 2010 | $1.20B | +38.6% | +$333.43M | ||
| 2009 | $864.25M | +1.8% | +$15.65M | ||
| 2008 | $848.60M | +106.1% | +$436.92M | ||
| 2007 | $411.68M | +66.4% | +$164.34M | ||
| 2006 | $247.34M | +241.2% | +$174.84M | ||
| 2005 | $72.50M | +0.3% | +$235.00K | ||
| 2004 | $72.26M | +52.5% | +$24.87M | ||
| 2003 | $47.39M | -33.9% | −$24.36M | ||
| 2002 | $71.74M | -32.8% | −$35.05M | ||
| 2001 | $106.79M | -13.9% | −$17.31M | ||
| 2000 | $124.10M | +287.4% | +$92.07M | ||
| 1999 | $32.03M | — | — |
- 2025$2.72B+14.7%
- 2024$2.37B-58.7%
- 2023$5.75B-12.9%
- 2022$6.60B-38.6%
- 2021$10.74B+128.8%
- 2020$4.69B+1.8%
- 2019$4.61B+20.0%
- 2018$3.85B+35.2%
- 2017$2.84B+25.3%
- 2016$2.27B+22.8%
- 2015$1.85B+26.4%
- 2014$1.46B-4.6%
- 2013$1.53B+16.3%
- 2012$1.32B+22.6%
- 2011$1.08B-10.2%
- 2010$1.20B+38.6%
- 2009$864.25M+1.8%
- 2008$848.60M+106.1%
- 2007$411.68M+66.4%
- 2006$247.34M+241.2%
- 2005$72.50M+0.3%
- 2004$72.26M+52.5%
- 2003$47.39M-33.9%
- 2002$71.74M-32.8%
- 2001$106.79M-13.9%
- 2000$124.10M+287.4%
- 1999$32.03M—
Total Equity values are taken from Illumina's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Illumina (ILMN)
According to Illumina's latest reported financial statements, the company's latest reported total equity is $2.68B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Illumina (ILMN) total equity totalled $2.72B – grew 14.7% year-over-year.
Through 2020–2025 (5 years), Illumina total equity delivered a -10.3% annualised rate; with a net decline across the window.
Illumina total equity peaked at $10.74B in 2021; the latest annual figure is $2.72B in 2025 (74.6% below peak).
The record annual total equity stands at $10.74B, reached in 2021; the historical low of $32.03M was recorded in 1999.
Illumina Total Equity by Year
Illumina Total Equity 2025: $2.72B
Illumina posted total equity of $2.72B in 2025, grew 14.7% from 2024.
Illumina Total Equity 2024: $2.37B
In 2024, Illumina reported total equity of $2.37B, plunged 58.7% below 2023.
Illumina Total Equity 2023: $5.75B
Illumina total equity in 2023 was $5.75B, declined 12.9% below 2022.
Illumina Total Equity 2022: $6.60B
2022's total equity for Illumina came in at $6.60B, plunged 38.6% below 2021.
Illumina Total Equity 2021: $10.74B
Illumina total equity in 2021 was $10.74B.
See more financial history for Illumina (ILMN).
Sector peers by Total Equity
Healthcare peers of Illumina (ILMN), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Illumina (ILMN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation